Greg joined Halloran Consulting Group in 2007. He focuses on helping emerging companies navigate the challenges of early product development while establishing appropriate clinical, regulatory, and compliance structures to drive efficient development.
He brings over 18 years of experience in worldwide regulatory affairs, quality assurance and clinical operations. Prior to joining Halloran, Greg was responsible for the regulatory affairs and quality assurance groups at ArQule as well as directing development operations for the oncology portfolio while managing the Company’s key strategic alliances in Japan with Kyowa Hakko Kogyo.
Prior to joining ArQule, Greg worked in the regulatory affairs at PAREXEL International, Antigenics, Genzyme and DepoTech. He has successfully filed multiple clinical trial applications (IND or equivalent), successfully obtained Orphan Drug designation and/or Fast Track designation for six individual products and has had extensive involvement with NDA/MAA submissions resulting in multiple product approvals.
Greg holds a B.S. in Biology from the University of North Carolina – Chapel Hill.
Industry Expertise (3)
Areas of Expertise (1)
Regulatory and Quality Systems
University of North Carolina – Chapel Hill: B.S. , Biology 1994
- Author Appearance